March 3, 2026

We are attending NextGen Biomed

Our COO Tom Bosschaerts is attending NextGen Biomed on 24 - 25 March in London.

Reach out if you want to discuss how to gain maximum insights from TCR sequencing data.

Book a meeting

Stay up to date

Subscribe to our newsletter to receive useful tips and information.

Thank you! Your submission has been received!

Oups ! Un problème s'est produit lors de l'envoi du formulaire.

Recommended articles

July 29, 2024

Interpretable deep learning in immunology

At ImmuneWatch, we embrace machine learning and (interpretable) deep learning in immunology. Based on T-cell sequencing data, we specialise in predicting what epitope a specific T-cell receptor will bind to.

October 14, 2024

T-Cell Monitoring in Cancer Vaccine Research

This poster showcased how ImmuneWatch DETECT is used for T-cell monitoring in cancer vaccine research, featuring a case study of a stage IV colorectal cancer patient.